Literature DB >> 1026408

Studies on the metabolism of vinyl chloride.

H Antweiler.   

Abstract

Vinyl chloride (VCM) is not carcinogenic by itself, it is bioactivated to the highly reactive alkylating oxirane chloroethylene oxide. Further metabolism, apparently, leads via an interaction of the primary alkylating metabolites with glutathion to S-(2-carboxy-methyl)-cysteine and thiodiacetic acid which are eliminated with the urine. Up to now, it has not been ascertained whether the oxirane alone is the essential carcinogenic factor or whether other metabolites are also involved in carcinogenicity. Likewise, it is still unknown whether the metabolites excreted in the urine might be used as biological criteria for exposure to VCM, because these metabolites probably can originate from a series of substances other than VCM. This problem could stimulate investigations on the possible carcinogenic activity of these substances.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1026408      PMCID: PMC1475241          DOI: 10.1289/ehp.7617217

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  9 in total

1.  Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxiran formation.

Authors:  H Greim; G Bonse; Z Radwan; D Reichert; D Henschler
Journal:  Biochem Pharmacol       Date:  1975-11-01       Impact factor: 5.858

2.  Mutagenicity of vinyl chloride, chloroethyleneoxide, chloroacetaldehyde and chloroethanol.

Authors:  C Malaveille; H Bartsch; A Barbin; A M Camus; R Montesano; A Croisy; P Jacquignon
Journal:  Biochem Biophys Res Commun       Date:  1975-03-17       Impact factor: 3.575

3.  The biological fate in rats of vinyl chloride in relation to its oncogenicity.

Authors:  T Green; D E Hathway
Journal:  Chem Biol Interact       Date:  1975-12       Impact factor: 5.192

4.  [Determination of 2 vinylchloride metabolites in urine].

Authors:  G Müller; K Norpoth
Journal:  Naturwissenschaften       Date:  1975-11

5.  Hepatotoxicity of vinyl chloride and 1,1-dichloroethylene. Role of mixed function oxidase system.

Authors:  E S Reynolds; M T Moslen; S Szabo; R J Jaeger; S D Murphy
Journal:  Am J Pathol       Date:  1975-10       Impact factor: 4.307

6.  Carcinogenic activity of alkylating agents.

Authors:  B L Van Duuren; B M Goldschmidt; C Katz; I Seidman; J S Paul
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

7.  Metabolism of 1,2-dichloroethane- 14 C in the mouse.

Authors:  S Yllner
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

8.  Metabolism of chloroacetate-1- 14 C in the mouse.

Authors:  S Yllner
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

9.  Studies on the metabolism of isopnosphamide (NSC-109724) in man.

Authors:  K Norpoth
Journal:  Cancer Treat Rep       Date:  1976-04
  9 in total
  5 in total

1.  Adipose tissue-liver crosstalk during pathologic changes caused by vinyl chloride metabolites in mice.

Authors:  Brenna R Kaelin; Collin M McKenzie; Karl W Hempel; Anna L Lang; Gavin E Arteel; Juliane I Beier
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-20       Impact factor: 4.219

2.  Hepatic angiosarcoma. Animal model: angiosarcoma of rats and mice induced by vinyl chloride.

Authors:  C B Hong; J M Winston; C C Lee
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

3.  Rapamycin attenuates liver injury caused by vinyl chloride metabolite chloroethanol and lipopolysaccharide in mice.

Authors:  Anna L Lang; Austin M Krueger; Regina D Schnegelberger; Brenna R Kaelin; Maxwell J Rakutt; Liya Chen; Gavin E Arteel; Juliane I Beier
Journal:  Toxicol Appl Pharmacol       Date:  2019-09-06       Impact factor: 4.219

4.  Chemical structure, reactivity, and carcinogenicity of halohydrocarbons.

Authors:  B L Van Duuren
Journal:  Environ Health Perspect       Date:  1977-12       Impact factor: 9.031

5.  Neoplastic and nonneoplastic effects of vinyl chloride in mouse lung.

Authors:  Y Suzuki
Journal:  Environ Health Perspect       Date:  1981-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.